Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
Abstract Background: Phosphoinositide-3-kinase, regulatory subunit 1 (PIK3R1) could regulate cancer cell proliferation important for cancer cell proliferation; however, its role in Hepatocellular carcinoma (HCC) remains largely unknown. Here, we investigated the role of PIK3R1 in HCC and examined t...
Guardado en:
Autores principales: | Ai,Xuejun, Xiang,Lei, Huang,Zhi, Zhou,Shi, Zhang,Shuai, Zhang,Tao, Jiang,Tianpeng |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602018000100242 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
por: Amir Mohamed Abdelhamid, et al.
Publicado: (2022) -
Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2
por: Al Refaey,Heba R., et al.
Publicado: (2021) -
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020) -
miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
por: Li F, et al.
Publicado: (2020) -
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
por: Li M, et al.
Publicado: (2016)